generics

Novartis blocks generic to MS blockbuster Gilenya in US patent dispute
Pharmaforum
Tue, 01/4/22 - 10:50 am
Novartis
Gilenya
patents
HEC Pharma
generics
multiple sclerosis
MS
Humana, Centene sue drugmakers, alleging anticompetitive practices on HIV drugs
BioPharma Dive
Thu, 12/16/21 - 10:45 am
Humana
Centene
generics
anticompetitive practices
Gilead Sciences
Bristol Myers Squibb
JNJ
Teva Pharmaceuticals
Viatris gets shot to shed infringement claims in long-running patent kerfuffle on AstraZeneca's Symbicort
Fierce Pharma
Tue, 12/14/21 - 11:33 pm
Viatris
generics
Symbicort
AstraZeneca
patents
COPD
asthma
Novartis petitions FDA to block 18 generic competitors for its megablockbuster heart drug until 2024
Endpoints
Mon, 12/6/21 - 10:52 am
Novartis
generics
Entresto
Sun Pharma yanks thousands of erectile dysfunction tablets after manufacturing mishap
Fierce Pharma
Mon, 11/22/21 - 10:32 am
Sun Pharma
generics
tadalafil
erectile dysfunction
product recalls
Cialis
EQT, Biontech investor family consider Sandoz bid
Yahoo/Reuters
Fri, 11/19/21 - 11:12 am
EQT
BioNTech
Sandoz
generics
Novartis
M&A
CPhI: As Covid-19 restrictions ease, an inspection backlog could have a big effect on new drugs, generics
Endpoints
Thu, 11/11/21 - 11:09 am
CPhI
pandemic
FDA
regulatory
COVID-19
inspections
generics
Swiss socialists say government should buy Sandoz
Pharmaforum
Mon, 11/8/21 - 10:38 am
Switzerland
Novartis
Sandoz
M&A
generics
Novartis looking into future of its Sandoz’ generics business
Pharmaforum
Tue, 10/26/21 - 10:30 am
Novartis
generics
Sandoz
Gates Foundation will provide $120 million to ensure generic production of Merck’s Covid-19 pill
Stat
Wed, 10/20/21 - 10:07 am
Gates Foundation
generics
COVID-19
antivirals
Merck
molnupiravir
Why Pacira Biosciences Stock Sank Today
Motley Fool
Mon, 10/4/21 - 11:04 pm
Pacira
eVenus
FDA
generics
EXPAREL
non-opioid pain treatments
Three generic firms shell out $447M more to settle federal price fixing allegations
Endpoints
Mon, 10/4/21 - 10:59 am
generics
legal
price fixing
Taro Pharmaceuticals
Sandoz
Novartis
Apotex
Gilead, Bristol Myers face lawsuit from major pharmacies over HIV generic drug delays
Endpoints
Wed, 09/29/21 - 11:01 am
Gilead Sciences
Teva Pharmaceutical
Bristol Myers Squibb
CVS
Rite Aid
generics
HIV
Faced with generic rivals, Amarin cuts 400-plus sales reps as part of revamped Vascepa strategy
Fierce Pharma
Thu, 09/23/21 - 10:29 pm
Amarin
Vascepa
layoffs
generics
Amgen scores Otezla patent win, protecting its blockbuster from Sandoz and Zydus generics until 2028
Fierce Pharma
Tue, 09/21/21 - 10:54 am
Amgen
Otezla
psoriasis
generics
Sandoz
market exclusivity
patents
Pharmacist-driven biosimilar substitution saves money
GaBI
Sat, 08/28/21 - 09:08 pm
biosimilars
generics
pharmacists
ASCO
Court upholds AbbVie's patents on blockbuster cancer drug Imbruvica, generics unlikely until 2032
Endpoints
Fri, 08/20/21 - 12:33 pm
AbbVie
Imbruvica
patents
legal
generics
FDA seeks input on pre-Hatch-Waxman ‘PANDA’ applications
RAPS.org
Thu, 08/12/21 - 10:56 pm
FDA
Hatch Waxman Act
generics
PANDAs
Pfizer halted Chantix distribution then recalled a dozen batches. Now, a generic's here to help fill the shortage
Fierce Pharma
Thu, 08/12/21 - 11:48 am
Pfizer
Chantix
generics
Par Pharmaceuticals
varenicline
FDA
Takeda Settles "Pay-for-Delay" Consumer Claims for $1.85 Million
BioSpace
Thu, 08/12/21 - 12:07 am
Takeda
pay-for-delay
ADHD
generics

Pages